Detection of primary epstein‐barr virus infection in a patient with x‐linked lymphoproliferative disease receiving immunoglobulin prophylaxis
- 1 April 1991
- journal article
- research article
- Published by Wiley in American Journal of Hematology
- Vol. 36 (4) , 294-296
- https://doi.org/10.1002/ajh.2830360416
Abstract
Serologic diagnosis for Epstein-Barr virus (EBV) infection is problematic when patients receive exogenous immunoglobulin. We recently diagnosed primary EBV infection by detecting EBV-determined nuclear antigen (EBNA) and EBV-DNA in peripheral blood mononuclear cells (PBMC) using immunofluorescence, in situ hybridization and polymerase chain reaction (PCR) techniques in a patient with X-linked lymphoproliferative disease (XLP) who received prophylactic immunoglobulins for EBV infection. These combined techniques may be helpful for early and accurate diagnosis of EBV infection in highly vulnerable patients.Keywords
This publication has 6 references indexed in Scilit:
- Immunovirological studies of fatal infectious mononucleosis in a patient with X-linked lymphoproliferative syndrome treated with intravenous immunoglobulin and interferon-αClinical Immunology and Immunopathology, 1990
- Latent and Replicating Forms of Epstein-Barr Virus DNA in Lymphomas and Lymphoproliferative DiseasesThe Journal of Infectious Diseases, 1989
- Detection of Epstein‐Barr virus in CNS lymphomas by in‐situ hybridizationNeurology, 1989
- Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome.The Journal of Experimental Medicine, 1989
- Epstein-Barr virus and human diseases: recent advances in diagnosisClinical Microbiology Reviews, 1988
- Cellular localization of an Epstein‐Barr virus (EBV)‐associated complement‐fixing antigen in producer and non‐producer lymphoblastoid cell linesInternational Journal of Cancer, 1973